Aptamer-modified gold nanoparticles for targeting breast cancer cells through light scattering

83Citations
Citations of this article
110Readers
Mendeley users who have this article in their library.
Get full text

Abstract

In this study, we demonstrated the potential use of nucleic acid ligand (aptamers) conjugated gold nanoparticles (AuNPs) for cancer cell detection. Through specific binding of the aptamers toward platelet-derived growth factor (PDGF), MDA-MB-231 and Hs578T cells (cancer cells) that over-express PDGF, interact with Apt-AuNPs to a greater extent than do H184B5F5/M10 cells (normal cells). These results were confirmed through inductively coupled plasma mass spectrometry measurements of the gold ion concentrations within these cells. Aggregation of the Apt-AuNPs in the cytoplasm of the cancer cells led to the generation of an intense scattered light upon photo-illumination; this phenomenon allows the differentiation of cancer cells from normal cells using a dark field optical microscope. The presence of Apt-AuNPs suppressed the proliferation of MDA-MB-231 cancer cells, but not H184B5F5/M10 cells. © 2008 Springer Science+Business Media B.V.

Cite

CITATION STYLE

APA

Huang, Y. F., Lin, Y. W., Lin, Z. H., & Chang, H. T. (2009). Aptamer-modified gold nanoparticles for targeting breast cancer cells through light scattering. Journal of Nanoparticle Research, 11(4), 775–783. https://doi.org/10.1007/s11051-008-9424-x

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free